Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

238.57
-8.2300-3.33%
Pre-market: 240.902.33+0.98%06:55 EDT
Volume:518.02K
Turnover:123.92M
Market Cap:16.75B
PE:41.24
High:244.54
Open:243.67
Low:237.50
Close:246.80
Loading ...

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

MT Newswires Live
·
07 Apr

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living With Type 1 Diabetes Ages Two Years and Above

THOMSON REUTERS
·
07 Apr

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

CNW Group
·
07 Apr

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Apr

Shares of Some US Medical Device Makers Down Between 3% and 5.5% After Trump's Reciprocal Tariffs

THOMSON REUTERS
·
03 Apr

Insulet and Dexcom Shares Down 5% Each, GE Healthcare, Boston Scientific and Stryker Shares Fall 3% Each

THOMSON REUTERS
·
03 Apr

Shares of US Medical Device Maker Extend Declines to Fall Between 5% and 9%

THOMSON REUTERS
·
03 Apr

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Business Wire
·
03 Apr

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Apr

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
28 Mar

3 Reasons Investors Love Insulet (PODD)

StockStory
·
27 Mar

Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
27 Mar

Insulet Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
25 Mar

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Zacks
·
24 Mar

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Simply Wall St.
·
23 Mar

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Zacks
·
22 Mar

Insulet Corp - on March 20, Enters Seventh Amendment to Credit Agreement - SEC Filing

THOMSON REUTERS
·
21 Mar

Insulet’s Strong Performance and Growth Prospects Drive Buy Rating

TIPRANKS
·
21 Mar

Insulet’s Omnipod 5 Gains Favorable Buy Rating Following RADIANT Study Success

TIPRANKS
·
20 Mar

Insulet’s Strategic Debt Restructuring: Buy Rating Reaffirmed Amid Margin and EPS Growth Prospects

TIPRANKS
·
20 Mar